A Study of ONO-1110 in Patients With Social Anxiety Disorder

Clinical trial NCT06805565 · COMPLETED

Trial details

NCT number: NCT06805565
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Social Anxiety Disorder (SAD)

Start date: 2025-01-31
Primary completion: 2026-05-25
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.